Global Endowment Management’s iShares Biotechnology ETF IBB Stock Holding History

Global Endowment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,780	Closed	-$577K	–	120
2021 Q4	$577K	Buy	3,780 +1,380	+58%	+$214K	0.04%	100
2021 Q3	$388K	Hold	2,400	–	–	0.03%	101
2021 Q2	$393K	Buy	+2,400	New	+$370K	0.02%	105
2020 Q4	–	Sell	-1,540	Closed	-$209K	–	132
2020 Q3	$209K	Hold	1,540	–	–	0.02%	118
2020 Q2	$211K	Sell	1,540 -910	-37%	-$116K	0.02%	101
2020 Q1	$264K	Hold	2,450	–	–	0.02%	86
2019 Q4	$295K	Hold	2,450	–	–	0.02%	94
2019 Q3	$244K	Hold	2,450	–	–	0.02%	84
2019 Q2	$267K	Hold	2,450	–	–	0.03%	160
2019 Q1	$274K	Sell	2,450 -1,210	-33%	-$133K	0.04%	196
2018 Q4	$353K	Sell	3,660 -1,465	-29%	-$155K	0.08%	117
2018 Q3	$625K	Hold	5,125	–	–	0.08%	130
2018 Q2	$563K	Buy	5,125 +625	+14%	+$66.8K	0.07%	143
2018 Q1	$480K	Hold	4,500	–	–	0.07%	144
2017 Q4	$480K	Hold	4,500	–	–	0.07%	139
2017 Q3	$500K	Hold	4,500	–	–	0.07%	158
2017 Q2	$465K	Sell	4,500 -4,500	-50%	-$443K	0.06%	164
2017 Q1	$880K	Hold	9,000	–	–	0.13%	116
2016 Q4	$796K	Hold	9,000	–	–	0.12%	113
2016 Q3	$868K	Hold	9,000	–	–	0.14%	101
2016 Q2	$772K	Buy	+9,000	New	+$808K	0.16%	83

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Global Endowment Management's IBB Position: Q1 2022 in Review

Global Endowment Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 3,780 shares — an estimated $577K sold.

Global Endowment Management first reported a position in IBB in Q2 2016 and held it in 21 quarters. The position peaked at $880K in Q1 2017. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Global Endowment Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Global Endowment Management sold 3,780 iShares Biotechnology ETF shares in Q1 2022, an estimated $577K.
Global Endowment Management first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 21 quarters.
Global Endowment Management's iShares Biotechnology ETF position peaked at $880K in Q1 2017.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Global Endowment Management's 13F filing for Q1 2022, filed 13 May 2022.